Common Contracts
11 similar Voting Agreement contracts by DiaMedica Therapeutics Inc.
DIAMEDICA INC. (the “Corporation”) - and - Werner Pauls (the “Shareholder”)Voting Agreement • November 9th, 2018 • DiaMedica Therapeutics Inc. • Pharmaceutical preparations • Manitoba
NOW THEREFORE, in consideration of the premises and of the mutual agreement and covenants set forth herein and in the Investment Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
DIAMEDICA INC. (the “Corporation”) - and - Michael Giuffre (the “Shareholder”)Voting Agreement • November 9th, 2018 • DiaMedica Therapeutics Inc. • Pharmaceutical preparations • Manitoba
NOW THEREFORE, in consideration of the premises and of the mutual agreement and covenants set forth herein and in the Investment Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
DIAMEDICA INC. (the “Corporation”) - and - Stephen Mullie (the “Shareholder”)Voting Agreement • November 1st, 2018 • DiaMedica Therapeutics Inc. • Pharmaceutical preparations • Manitoba
NOW THEREFORE, in consideration of the premises and of the mutual agreement and covenants set forth herein and in the Investment Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
DIAMEDICA INC. (the “Corporation”) - and - Chris Pauls (the “Shareholder”)Voting Agreement • November 1st, 2018 • DiaMedica Therapeutics Inc. • Pharmaceutical preparations • Manitoba
NOW THEREFORE, in consideration of the premises and of the mutual agreement and covenants set forth herein and in the Investment Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
DIAMEDICA INC.Voting Agreement • November 1st, 2018 • DiaMedica Therapeutics Inc. • Pharmaceutical preparations • Manitoba
NOW THEREFORE, in consideration of the premises and of the mutual agreement and covenants set forth herein and in the Investment Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
DIAMEDICA INC. (the “Corporation”) - and - Michael Giuffre (the “Shareholder”)Voting Agreement • August 27th, 2018 • DiaMedica Therapeutics Inc. • Pharmaceutical preparations • Manitoba
NOW THEREFORE, in consideration of the premises and of the mutual agreement and covenants set forth herein and in the Investment Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
DIAMEDICA INC.Voting Agreement • August 27th, 2018 • DiaMedica Therapeutics Inc. • Pharmaceutical preparations • Manitoba
NOW THEREFORE, in consideration of the premises and of the mutual agreement and covenants set forth herein and in the Investment Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
DIAMEDICA INC. (the “Corporation”) - and - Rick Pauls (the “Shareholder”)Voting Agreement • August 27th, 2018 • DiaMedica Therapeutics Inc. • Pharmaceutical preparations • Manitoba
NOW THEREFORE, in consideration of the premises and of the mutual agreement and covenants set forth herein and in the Investment Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
DIAMEDICA INC. (the “Corporation”) - and - Stephen Mullie (the “Shareholder”)Voting Agreement • August 27th, 2018 • DiaMedica Therapeutics Inc. • Pharmaceutical preparations • Manitoba
NOW THEREFORE, in consideration of the premises and of the mutual agreement and covenants set forth herein and in the Investment Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
DIAMEDICA INC. (the “Corporation”) - and - Chris Pauls (the “Shareholder”)Voting Agreement • August 27th, 2018 • DiaMedica Therapeutics Inc. • Pharmaceutical preparations • Manitoba
NOW THEREFORE, in consideration of the premises and of the mutual agreement and covenants set forth herein and in the Investment Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
DIAMEDICA INC. (the “Corporation”) - and - Werner Pauls (the “Shareholder”)Voting Agreement • August 27th, 2018 • DiaMedica Therapeutics Inc. • Pharmaceutical preparations • Manitoba
NOW THEREFORE, in consideration of the premises and of the mutual agreement and covenants set forth herein and in the Investment Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
